Sign In
Buy NDAQ
$77.65
-3.96 (-4.85%)
At Close: Jun 25, 2026
Foxx Development Closes Business Combination with Acri Capital Acquisition Corporation and Will Begin Trading on Nasdaq
04:00pm, Thursday, 26'th Sep 2024
Business Combination between Foxx Development Inc. and Acri Capital Acquisition Corporation closed on September 26, 2024 Trading of common stock and warrants of the new public company, Foxx Developmen
Nasdaq Q3 Preview: Improving IPO Activity Could Start In H1 FY25
08:58am, Thursday, 26'th Sep 2024
Nasdaq's Solutions business continues to show double-digit growth, driven by strong ARR and increasing SaaS revenue, supporting a 'Strong Buy' rating with a fair value of $95 per share. The acquisitio
BioAge Labs IPO: Stock price will be closely watched today as the obesity drug developer debuts on the Nasdaq
08:31am, Thursday, 26'th Sep 2024
BioAge Labs is having its initial public offering today. The drug developer's signature product, Azelaprag, isn't yet on sale, but it is undergoing clinical trials in hopes it will one day be.
Nasdaq set to lead Wall Street higher as Micron fuels AI stocks
07:46am, Thursday, 26'th Sep 2024
Wall Street was set for a bright start on Thursday, with the Nasdaq expected to jump at the open following well-received earnings from Micron Technology Inc (NASDAQ:MU). Futures had the Nasdaq adding
Nasdaq Expands Presence in Latin America With New Agreement
02:51pm, Wednesday, 25'th Sep 2024
Nasdaq extends agreement with Nubank to provide AxiomSL regulatory reporting solution to the later and expands presence in Latin America.
HeartCore's Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
08:30am, Wednesday, 25'th Sep 2024
Company anticipates Q3 2024 revenue to be between $19 million-$23 million and net profit to be between $4 million-$8 million Company anticipates Q3 2024 revenue to be between $19 million-$23 million a
SHENZHEN, China , Sept. 25, 2024 /PRNewswire/ -- Big Tree Cloud Holdings Limited ("Big Tree Cloud" or the "Company") (NASDAQ: DSY) (NASDAQ: DSYWW), a company devoted to the development, production, an
District Provides Notice to Shareholders who Seek to Transfer Shares in Preparation for Nasdaq First North Growth Listing
02:00am, Wednesday, 25'th Sep 2024
Vancouver, British Columbia--(Newsfile Corp. - September 25, 2024) - District Metals Corp. (TSXV: DMX) (OTCQB: DMXCF) (FSE: DFPP); ("District" or the "Company") is pleased to provide notice to shareho
Banzai Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
09:00pm, Tuesday, 24'th Sep 2024
SEATTLE, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology company that provides essential marketing and
Nasdaq Leads Another Stock Market Advance; TSMC Scores Breakout As Nvidia Awakes From Slumber
05:25pm, Tuesday, 24'th Sep 2024
The Nasdaq reversed higher above the 18,000 level in the stock market Tuesday, helped by strength in Taiwan Semiconductor and Nvidia.
Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date September 13, 2024
04:05pm, Tuesday, 24'th Sep 2024
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- At the end of the settlement date of September 13, 2024, short interest in 3,057 Nasdaq Global MarketSM securities totaled 12,241,625,467 shares compared w
BlackRock's Mitchnick on ETF Custody, Nasdaq Listing IBIT Options, Crypto-Stock Correlation
03:58pm, Tuesday, 24'th Sep 2024
BlackRock Head of Digital Assets Robbie Mitchnick discusses crypto ETF custody, SEC approving Nasdaq to list IBIT options, crypto-stock correlation and Ether ETFs. He speaks with Sonali Basak and Mike
Nasdaq Surges 100 Points; Thor Industries Earnings Top Views
12:42pm, Tuesday, 24'th Sep 2024
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday.
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:05pm, Monday, 23'rd Sep 2024
SAN DIEGO , Sept. 23, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide
Nasdaq to Hold Third Quarter 2024 Investor Conference Call
04:05pm, Monday, 23'rd Sep 2024
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Nasdaq (Nasdaq: NDAQ) has scheduled its third quarter 2024 financial results announcement.
